Regimen Recommendations for Infective Endocarditis
Current American Heart Association Recommendations Regarding Infective Endocarditis
What Are The Major Changes?
Developed by a committee from the AHA, and adopted by the ADA, in April 2007 it has been concluded that antibiotic treatments prior to most dental procedures are unnecessary and ineffectual based on the following findings:
- Antibiotic Prophylaxis may prevent an extremely small number of cases of IE in patients who have a dental procedure. Moreover, this is under the assumption that the antibiotics would be 100% effective, which they are not.
- The risk of adverse effects from the antibiotics, such as creating drug resistant bacteria or patients having a bad reaction to the antibiotics, outweigh the possible benefits.
- IE is far more likely to occur from the bacteria released during daily hygiene events, such as brushing and flossing, then during any given dental procedure. In fact, over the course of a year the release of bacteria during daily activities may be as high as 5.6 million times greater† than during a single tooth extraction, the dental procedure reported to cause the greatest release of bacteria.
- The AHA guidelines emphasize that maintaining optimal oral health and practicing daily oral hygiene are more important in reducing the risk of IE than taking preventive antibiotics before a dental visit.
Who Should Still Receive Antibiotic Prophylaxis?
Infective endocarditis prophylaxis for dental procedures should be recommended only for patients with underlying cardiac conditions associated with the highest risk of adverse outcome from infective endocarditis.
People with the following conditions should still receive preventive antibiotics prior to Dental Procedures that involve manipulation of gingival tissue, or the periapical region of teeth, or perforation of the oral mucosa††. The new recommendations apply to many dental procedures, including teeth cleaning and extractions.
- Artificial Cardiac Valves
- Previous Infective Endocarditis
- Congenital Heart Disease (CHD) with the following conditions††*:
- Unrepaired cyanotic CHD, including palliative shunts and conduits
- Completely repaired congenital heart defect with prosthetic material or device, whether placed by surgery or by catheter intervention; during the first six months after the procedure††**.
- Any repaired congenital heart disease with residual defects at the site or adjacent to the site of a prosthetic patch or a prosthetic device (which inhibit endothelialization).
- A cardiac transplantation recipient who develops a cardiac valvulopathy.
What About Patients Who Regularly Took Antibiotics Because Of Heart Conditions?
If you have the following conditions and have taken prophylactic antibiotics routinely in the past; you no longer need them:
- Mitral valve prolapse
- Rheumatic heart disease
- Bicuspid valve disease
- Calcified aortic stenosis
- Congenital heart conditions such as ventricular septal defect, atrial septal defect and hypertrophic cardiomyopathy.
Moreover, prophylaxis is not recommended based solely on an increased lifetime risk of acquisition of infective endocarditis.
The new guidelines are aimed at patients who would have the greatest danger of a bad outcome if they developed a heart infection.
Specific Situations and Circumstances:
- Patients currently on antibiotics: If a patient is currently taking an antibiotic normally used for endocarditis prophylaxis, it is prudent to select a drug from a different class rather than to increase the dose of the current antibiotic.
- Complicated circumstances can occur in patients with congenital heart disease. If there is any concern as to which category best fits their needs they need to check with their cardiologist.
- Patients with previous coronary artery bypass surgery, cardiac pacemakers (intravascular and epicardial), and implanted defibrillators should still not receive endocarditis prophylaxis.
- When antibiotics are suggested before a dental or medical procedure careful questions should be asked of the health care provider recommending the antibiotics.
Antibiotic Prophylaxis for Dental Patients with Total Joint Replacement:**##
Please note that as of May 2007 there has been no official revision of the guidelines regarding prophylaxis for IE. It is recommended that you consult your physician prior to dental treatment.
- Patients at Potential Increased Risk of Hematogenous Total Joint Infection Immunocompromised / Immunosuppressed Patients:
- Inflammatory arthropathies: rheumatoid arthritis, systemic lupus erythematosus
- Disease, drug, or radiation–induced immunosuppression
- Other Patients:
- Insulin–dependent (Type 1) diabetes
- First two years following joint placement
- Previous prosthetic joint infections